Sept. 16, 2019 – Five research studies conducted by the FDA’s Office of Prescription Drug Promotion (OPDP) – four of which examine aspects of direct-to-consumer (DTC) advertising – are complete and awaiting peer review and publication, according to OPDP’s Website. “Taken together, the OPDP studies now nearing release will make an important contribution to the […]
Read more
Sept. 2, 2019 – Although healthcare marketing communicators and publishers are busy professionals with a lot on their plates, staying on top of healthcare policy developments in Washington, D.C., can both enhance and further their careers, according to panelists speaking at the recent Coalition for Healthcare Communication Rising Leaders Conference on Healthcare Policy. “Every time […]
Read more
Aug. 19, 2019 – As presidential hopefuls discuss the possible merits of “Medicare for All” and other healthcare reforms, discourse in the nation’s capital has deteriorated to the point where “no one talks to each other,” according to Kay Holcombe, who recently retired as senior vice president for science policy at the Biotechnology Innovation Organization. […]
Read more
July 22, 2019 – Social science research conducted at the FDA’s Office of Prescription Drug Promotion (OPDP) is designed to investigate issues relevant to healthcare professional and consumer use of medical product information, to consider the audience’s perception and comprehension of that information, and to assess the accuracy and effectiveness of promotional messaging, according to […]
Read more
July 8, 2019 – A growing spotlight on data privacy will lead the federal government to create national data privacy regulation in lieu of a patchwork of different regulations spanning 50 states, according to Alison Pepper, senior vice president for Government Relations at the 4A’s. Speaking at the recent Coalition for Healthcare Communication’s Rising Leaders […]
Read more
June 17, 2019 – The Trump administration’s final rule mandating that drug companies include the wholesale acquisition cost (WAC) in direct-to-consumer (DTC) television ads for many drugs “exceeds [the Department of Health and Human Services’ (HHS’)] statutory authority, violates the First Amendment, and should therefore be set aside,” according to a lawsuit filed Friday, less […]
Read more
June 11, 2019 – Although pharmaceutical advertisers have been able to stop legislation to eliminate or reduce the deductibility of drug advertising as a business expense in the past, the times, politics and a pressing need for revenue have changed the equation, according to Jim Davidson, chair of The Advertising Coalition. “It is very much […]
Read more May 30, 2019 –As “the outrage around privacy incidents continues to get a little bit louder every year,” many states have already made significant moves to regulate data privacy and fill the gaps left by a lack of federal legislation, Alison Pepper, senior vice president for Government Relations at the 4A’s, told the Rising Leaders […]
Read more
May 23, 2019 – Concern over drug pricing remains a healthcare policy issue that enjoys bipartisan support and will remain on the table for the Trump administration and Congress as campaigns for the 2020 election ramp up, according to Kate Rawson, senior editor at Prevision Policy. Speaking at a session of the Coalition for Healthcare […]
Read more
May 16, 2019 — Exactly how do laws get crafted or regulations finalized in Washington in the year 2019? Kay Holcombe—who has been an FDA official, a key staffer in both the Senate and the House, and Senior VP of BIO—will share her informed perspective on “how the sausage gets made” at this year’s Rising Leaders […]
Read more